Cite

    Sheth, V. et al. (2018). Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation. Pediatric blood & cancer. 65 (11), p. n/a. [Online].